Extraordinary General Meeting

Report this content

To the shareholders of FluoGuide A/S

Til aktionærerne i FluoGuide A/S (Dansk version nedenfor)

The board of directors hereby convenes an extraordinary general meeting of FluoGuide A/S, CVR no. 39 29 64 38, (the ”Company”), to be held on: 

Monday 17 February 2020 at 11:00 (CET)

at the Company’s premises, Ole Maaløes Vej 3, DK-2200 Copenhagen N, Denmark, room M2

Agenda

  1. Authorisation to the board of directors to increase the share capital at market price or at a rate discounted to the market price without pre-emption rights for existing shareholders
  2. Documents for the general meeting shall in the future only be prepared in English.

---

Items on the agenda, including complete proposals

Item 1: Authorisation to the board of directors to increase the share capital at market price or at a rate discounted to the market price without pre-emption rights for existing shareholders  

The board of directors of the Company has, subject to authorisation from the general meeting, decided to conduct a directed share issue of approx. MDKK 11.6 (before issue costs of approx. MDKK 0.5). Participants in the directed share issue is, amongst others, the institutional investors A/S Arbejdernes Landsbank and Linc AB, a Swedish based life science investor with a long list of successful investments.

Accordingly, in order to implement the contemplated directed issue of shares the board of directors proposes that the general meeting increases the existing authorisation to the board of directors in article 3.2.2 of the articles of association to increase the Company’s share capital in one or more issues of new shares without pre-emption rights for the Company’s existing shareholders by up to nominally DKK 223,099.40 from previously nominally DKK 81,000.00. According to the existing authorisation the capital increase shall be made at market price. The subscription price for the contemplated issue of shares is DKK 5.20 per share which corresponds to the market-based price determined by the board of directors based on a twenty-day average volume-weighted price for the Company's shares prior to the board of directors’ decision to conduct a directed share issue with a discount of approx. 10 percent. In order to take account for the discount to the market price it is proposed to amend the existing authorisation to the effect that the authorisation also allows for capital increases at a rate discounted to the market price. The capital increase shall take place by way of cash contribution.

Adoption of the proposal will result in an updated clause 3.2.2 of the articles of association of the Company with the following wording:

3.2.2 Bestyrelsen er i perioden fra den 17. februar 2020 og indtil den 30. juni 2020 bemyndiget til uden fortegningsret for Selskabets eksisterende aktionærer at forhøje Selskabets aktiekapital ad én eller flere gange med i alt op til nominelt DKK 223.099,40. Kapitalforhøjelsen skal ske til markedskurs eller med en rabat i forhold til markedskursen. Kapitalforhøjelsen skal ske ved kontant indbetaling.   In the period from 1 July 2019 and until 30 June 2020, the board of directors is authorised to increase the Company’s share capital in one or more issues of new shares without pre-emption rights for the Company’s existing shareholders by up to a nominal amount of DKK 223,099.40. The capital increase shall take place at market price or at a rate discounted to the market price. The capital increase shall take place by way of cash contribution.

As VP Investor Services A/S has changed name to VP Services A/S, it is proposed that clauses 2.5, 5.9, 5.11 of the articles of association will be changed accordingly.

Item 2: Documents for the general meeting shall in the future only be prepared in English

The board of directors of the Company proposed that in the future documents prepared for the general meeting shall be prepared in English only, ref. section 110(6) of the Danish Companies Act.

---

Majority requirements
The proposal on item 1 of the agenda shall be adopted by 2/3 majority of votes cast as well as of the share capital represented at the extraordinary general meeting. 

The proposal on item 2 of the agenda shall be adopted by simple majority of votes.

Share capital 
At the time of the notice of the general meeting, the Company’s nominal share capital is DKK 722,427.40, divided into shares of nominally DKK 0.10 each. Each share of DKK 0.10 carries one vote. 

Registration date and shareholders’ voting rights 
The registration date is Thursday 11 February 2020.

The right of a shareholder to attend a general meeting and to vote is determined on the basis of the number of shares held by the shareholder at the registration date. The shares held by each shareholder are determined at the registration date based on the number of shares held by that shareholder as registered in the Company’s register of shareholders and on any notification of ownership received by the Company at the registration date for the purpose of registration in the Company’s register of shareholders, which have not yet been registered. Participation is conditional upon the shareholder having obtained an admission card in due time as described below.

Admission cards 
Shareholders who are entitled to attend the general meeting and who wish to attend the general meeting must request an admission card no later than on Friday 14 February 2020 at 23:59 (CET). 

Admission cards for the general meeting may be obtained by using the registration form, which is available on the Company’s website, https://fluoguide.com/investor/general-meeting/. The completed and signed form must be scanned and returned by email to the Company (info@fluoguide.com) or send by ordinary mail to FluoGuide A/S, Ole Maaløes Vej 3, DK-2200 Copenhagen N, Denmark.

Admission cards ordered will be distributed to the email address which has been stated on the registration form.  Admission cards and the related ballot papers must be printed and brought to general meeting. If it is not possible for you to print your admission card and ballot paper, please contact the Company by email to info@fluoguide.com.

Proxy 
Subject to having requested an admission card, shareholders may attend the general meeting in person or by proxy. Proxies may be obtained by using the proxy form, which is available on the Company’s website, https://fluoguide.com/investor/general-meeting/. The completed and signed form must be scanned and returned by email to the Company (info@fluoguide.com) or send by ordinary mail to FluoGuide A/S, Ole Maaløes Vej 3, DK-2200 Copenhagen N, Denmark.

Proxy forms must be received by the Company no later than on Friday 14 February 2020 at 23:59 (CET)

It is possible to submit either proxy or vote by correspondence, cf. below, but not both.

The right to attend and vote by proxy is subject to presentation of appropriate identification. If appropriate identification is not presented, attendance and/or voting right may be rejected.

Voting by correspondence 
Shareholders who are not able to attend the general meeting may vote by correspondence. Votes by correspondence may be obtained by using the voting by correspondence form, which is available on the Company’s website, https://fluoguide.com/investor/general-meeting/. The completed and signed form must be scanned and returned by email to the Company (info@fluoguide.com) or send by ordinary mail to FluoGuide A/S, Ole Maaløes Vej 3, DK-2200 Copenhagen N, Denmark.

Votes by correspondence must be received by the Company no later than on Wednesday 12 February 2020 at 16:00 (CET).

It is possible to submit either proxy or vote by correspondence, cf. above, but not both.

Additional information
Until and including the day of the general meeting, additional information regarding the general meeting will be available on the Company’s website, https://fluoguide.com/investor/general-meeting/, including: 

The notice to convene the general meeting, including the agenda and the complete proposals; 

The proxy/voting by correspondence form for use in connection with voting by proxy or by correspondence; and

The aggregated number of shares and voting rights as of the date of the notice to convene the general meeting (https://fluoguide.com/investor/ownership/).

Questions from the shareholders 
Shareholders may ask questions regarding the agenda and documents concerning the general meeting may be submitted in writing prior to general meeting by ordinary mail to the Company to the address Ole Maaløes Vej 3, DK-2200 Copenhagen N, or by email to info@fluoguide.com. Questions must be received no later than Friday 14 February 2020. 

Personal data
With regards to collection and processing of personal data, reference is made to the Company’s information sheet on data protection in connection with general meetings, which is available on the Company’s website, https://fluoguide.com/investor/legal-gdpr/.

Copenhagen, 31 January 2020

FluoGuide A/S 
The board of directors

 

--------

Dansk version: 

INDKALDELSE TIL GENERALFORSAMLING 

Til aktionærerne i FluoGuide A/S 

Bestyrelsen indkalder herved til ekstraordinær generalforsamling i FluoGuide A/S, CVR-nr. 39 29 64 38, (”Selskabet”), der afholdes: Mandag, den 17. februar 2020, kl. 11.00 på Selskabets adresse Ole Maaløes Vej 3, 2200 København, lokale M2.

Dagsorden 

1. Forslag om bemyndigelse til bestyrelsen til at forhøje selskabskapitalen til markedspris eller med en rabat i forhold til markedsprisen uden fortegningsret for de eksisterende kapitalejere.

2. Forslag om at dokumenter til brug for generalforsamlingen i fremtiden kun skal forelægge på engelsk.

Dagsorden med fuldstændige forslag 

Ad punkt 1: Forslag om bemyndigelse til bestyrelsen til at forhøje selskabskapitalen til markedspris eller med en rabat i forhold til markedsprisen uden fortegningsret for de eksisterende kapitalejere 

Selskabets bestyrelse har med forbehold for at generalforsamlingen bemyndiger bestyrelsen hertil besluttet at gennemføre en rettet emission af aktier på ca. MDKK 11,6 (før emissionsomkostninger på ca. MDKK 0,5). Deltagere i den rettede emission er blandt andet de institutionelle investorer A / S Arbejdernes Landsbank og Linc AB, som er en svenskbaseret life science investor, der har gennemfør en lang liste af succesrige investeringer. 

For at gennemføre den påtænkte rettede emission af aktier foreslår bestyrelsen, at generalforsamlingen forhøjer den eksisterende bemyndigelse til bestyrelsen i vedtægternes punkt 3.2.2 til at forhøje Selskabets aktiekapital ad én eller flere gange ved udstedelse af aktier uden fortegningsret for Selskabets eksisterende aktionærer til nominelt DKK 223.099,40 fra tidligere nominelt DKK 81.000,00. I henhold til den eksisterende bemyndigelse skal kapitalforhøjelser ske til markedspris. Tegningskursen for den påtænkte udstedelse af aktier er DKK 5,20 pr. aktie, hvilket svarer til den markedsbaserede kurs, der er fastlagt af bestyrelsen baseret på en tyve-dages gennemsnitlig volumenvægtet kurs for Selskabets aktier forud for bestyrelsens beslutning om at gennemføre en rettet emission med en rabat på ca. 10 %. For at tage højde for rabatten i forhold til markedsprisen foreslås det at ændre den eksisterende bemyndigelse, således at bemyndigelsen også giver mulighed for at gennemføre kapitalforhøjelser til en kurs med en rabat i forhold til markedsprisen. Kapitalforhøjelse skal ske ved kontant betaling.

Med de foreslåede ændringer vil vedtægternes pkt. 3.2.2 have følgende ordlyd:

3.2.2 Bestyrelsen er i perioden fra den 17. februar 2020 og indtil den 30. juni 2020 bemyndiget til uden fortegningsret for Selskabets eksisterende aktionærer at forhøje Selskabets aktiekapital ad én eller flere gange med i alt op til nominelt DKK 223.099,40. Kapitalforhøjelsen skal ske til markedskurs eller med en rabat i forhold til markedskursen. Kapitalforhøjelsen skal ske ved kontant indbetaling.   In the period from 1 July 2019 and until 30 June 2020, the board of directors is authorised to increase the Company’s share capital in one or more issues of new shares without pre-emption rights for the Company’s existing shareholders by up to a nominal amount of DKK 223,099.40. The capital increase shall take place at market price or at a rate discounted to the market price. The capital increase shall take place by way of cash contribution.

Da VP Investor Services A / S har ændret navn til VP Services A / S, foreslås det, at vedtægternes pkt. 2.5, 5.9, 5.11 ændres i overensstemmelse hermed.

Ad punkt 2: Forslag om at dokumenter til brug for generalforsamlingen i fremtiden kun skal forelægge på engelsk

Bestyrelsen foreslår, at dokumenter til brug for generalforsamlingen i fremtiden kun skal forelægge på engelsk, jf. selskabslovens jf. § 110, stk. 6.

----

Majoritetskrav 

Forslaget i dagsordenens punkt 1 kræver tilslutning fra mindst 2/3 såvel af de på generalforsamlingen afgivne stemmer, som af den del af selskabskapitalen, der er repræsenteret på generalforsamlingen. 

Forslaget i dagsordenens punkt 2 kan vedtages med simpelt flertal. 

Aktiekapitalens størrelse 

På tidspunktet for indkaldelsen er Selskabets aktiekapital nominelt kr. 722,427.40, der er fordelt på aktier à nominelt kr. 0,10. Hvert aktiebeløb på kr. 0,10 giver én stemme.  

Registreringsdato og aktionærernes stemmeret 

Registreringsdatoen er tirsdag den 11. februar 2020. 

Aktionærer, der besidder aktier i Selskabet på registreringsdatoen, har ret til at deltage i og stemme på generalforsamlingen. De aktier, aktionæren besidder, opgøres på registreringsdatoen på baggrund af notering af aktionærens aktier i ejerbogen samt meddelelser om ejerforhold, som Selskabet har modtaget med henblik på indførsel i ejerbogen. Deltagelse er i øvrigt betinget af, at aktionæren rettidigt har løst adgangskort som nærmere beskrevet nedenfor. 

Adgangskort  

Aktionærer, som er berettiget til og ønsker at deltage i generalforsamlingen, skal anmode om adgangskort senest fredag den 14. februar 2020, klokken 23:59.  

Adgangskort med stemmesedler til generalforsamlingen kan bestilles på Selskabets hjemmeside, https://fluoguide.com/investor/general-meeting/. Blanketten sendes i udfyldt og underskrevet stand til Selskabet, enten via indscannet via e-mail til info@fluoguide.com eller pr. post til FluoGuide A/S, Ole Maaløes Vej 3, 2200 København Ø.

Bestilte adgangskort vil blive sendt til den mailadresse, der er angivet på tilmeldingsblanketten. Adgangskort med dertilhørende stemmesedler skal printes og medbringes på generalforsamlingen. Har man ikke mulighed for selv at printe sit adgangskort og stemmeseddel, skal man kontakte Selskabet ved at skrive til info@fluoguide.com.

Fuldmagt 

Aktionærer, der har anmodet om et adgangskort, kan møde fysisk eller ved fuldmagt på generalforsamlingen. Fuldmagt kan afgives ved brug af fuldmagts- og brevstemmeblanket, der kan hentes på Selskabets hjemmeside, https://fluoguide.com/investor/general-meeting/. Blanketten scannes og sendes i udfyldt og underskrevet stand til Selskabet, enten via e-mail til info@fluoguide.com eller pr. post til FluoGuide A/S, Ole Maaløes Vej 3, 2200 København Ø. 

Fuldmagter skal være Selskabet i hænde senest fredag den 14. februar 2020, klokken 23:59.  

Der kan afgives enten fuldmagt eller brevstemme, jf. nærmere nedenfor, men ikke begge dele. 

Retten til fremmøde og afgivelse af stemmer ved fuldmægtig skal godtgøres ved behørig dokumentation. Såfremt behørig dokumentation ikke kan fremlægges, kan adgang og/eller stemmeret efter omstændighederne blive nægtet. 

Brevstemme 

Aktionærer, der er forhindret i at deltage i generalforsamlingen, kan stemme ved brev. Brevstemme kan afgives ved brug af fuldmagts- og brevstemmeblanket, der kan hentes på Selskabets hjemmeside, https://fluoguide.com/investor/general-meeting/. Blanketten scannes og sendes i udfyldt og underskrevet stand til Selskabet enten via e-mail til info@fluoguide.com eller pr. post til FluoGuide A/S, Ole Maaløes Vej 3, 2200 København Ø. 

Brevstemmer skal være Selskabet i hænde senest onsdag, den 12. februar 2020, klokken 16:00. 

Der kan afgives enten brevstemme eller fuldmagt, jf. nærmere ovenfor, men ikke begge dele. 

Yderligere oplysninger 

På Selskabets hjemmeside, https://fluoguide.com/investor/general-meeting/, vil der til og med dagen for generalforsamlingen kunne findes yderligere oplysninger om generalforsamlingen, herunder:  

Indkaldelsen til generalforsamlingen, herunder dagsordenen med de fuldstændige forslag.

Fuldmagts- og brevstemmeblanket, der anvendes ved stemmeafgivelse ved fuldmagt eller ved brev.

Oplysninger om det samlede antal aktier og stemmerettigheder på datoen for indkaldelsen (https://fluoguide.com/investor/ownership/). 

Spørgsmål fra aktionærerne 

Aktionærer kan forud for generalforsamlingen stille spørgsmål til dagsordenen eller til dokumenter m.v. til brug for generalforsamlingen ved skriftlig henvendelse til Selskabet på adressen Ole Maaløes Vej 3, 2200 København Ø, eller pr. e-mail til info@fluoguide.com. Spørgsmål skal være Selskabet i hænde senest fredag den 14. februar 2020.  

København, den 31. januar 2020

FluoGuide A/S  

Bestyrelsen


For further information, please contact:
Morten Albrechtsen, CEO
M: +45 24 25 62 66
ma@fluoguide.com

__________________________________________________________________________________

About FluoGuide 
FluoGuide A/S (Spotlight Stock Market: FLUO:SS) provides solutions for maximizing surgical outcome through intelligent targeting. FluoGuide’s first product FG001 increases precision in cancer surgery by lighting up the cancer and its invasive growth into the surrounding tissue. FG001 is expected to reduce suffering for the patients and increase the likelihood of cure. It can also reduce costs for the health care system for the benefit of society. FluoGuide focuses on demonstrating the effect of FG001 in patients by conducting a human proof-of-concept clinical trial and expects to announce the first result of this study during first half of 2020.

About FG001
FG001, FluoGuide’s first product, lights up the cancer and its invasive growth into the surrounding tissue. It helps the surgeon remove the entire tumor during surgery and increases the chance for complete cure of the patient. The task for the surgeon is simply to "turn the lights on and see the entire tumor". The solution helps surgeons remove a minimal amount of normal tissue while also reducing the risk of leaving cancer tissue behind. This reduces the suffering of the patient and increases the likelihood of cure, and also reduces costs for the health care system. FG001 is currently prepared for a proof-of-concept clinical study.